June 1, 2026 · Form 4 insider transaction
Patel Jeegar Pravinkumar bought 13,512 shares of Evommune, Inc. at $3.84 per share, a transaction worth $51.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.